EW

Edwards Lifesciences
D

EW

Arincen78/100B

Edwards Lifesciences earnings

Edwards Lifesciences reports its Q4 FY2026 results on 9 February 2027, after the market closes. Analysts expect earnings per share of 0.66 USD and revenue of 1.71B USD.

In Q3 FY2026, reported on 4 November 2026, Edwards Lifesciences earned 0.80 USD a share against the 0.74 USD analysts expected (+7.5%), on revenue of 1.72B USD against 1.68B USD (+2.1%).

Last EPS surprise
+7.5%
Last revenue surprise
+2.1%
Move after the last report
+1.5%
Average move after earnings
5.6%

EPS and revenue against estimates

Next earnings · Q4 FY2026
EPS estimate
0.66 USD
Revenue estimate
1.71B USD
Last quarter · Q3 FY2026
EPS0.80Beat +7.5%Revenue1.72BBeat +2.1%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growthNext-day move
Q3 FY20270.87——+8.57%1.89B——+10.07%—
Q2 FY20270.87——+12.16%1.90B——+9.02%—
Q1 FY20270.84——+7.96%1.80B——+8.91%—
Q4 FY20260.66——+13.79%1.71B——+8.86%—
Q3 FY20260.740.80+7.53%+19.40%1.68B1.72B+2.10%+10.46%+1.5%
Q2 FY20260.740.78+4.98%+16.42%1.70B1.74B+2.40%+13.63%-1.4%
Q1 FY20260.730.78+7.00%+21.88%1.60B1.65B+3.24%+16.70%+5.6%
Q4 FY20250.620.58-6.15%-1.69%1.55B1.57B+1.47%+13.26%+3.0%
Q3 FY20250.600.67+12.42%0.00%1.50B1.55B+3.69%+14.67%-1.2%
Q2 FY20250.620.67+7.37%-4.29%1.49B1.53B+2.97%+10.56%+5.5%
Q1 FY20250.600.64+7.38%-3.03%1.40B1.41B+0.87%-11.61%+6.8%
Q4 FY20240.550.59+7.08%-7.81%1.36B1.39B+1.98%-9.67%+6.9%
Q3 FY20240.670.67+0.75%+13.56%1.54B1.35B-12.31%-8.54%-1.4%
Q2 FY20240.690.70+1.45%+6.06%1.65B1.39B-16.17%-9.43%-31.4%
Q1 FY20240.640.66+3.13%+6.45%1.57B1.60B+1.80%+9.50%-1.8%
Q4 FY20230.640.640.00%0.00%1.49B1.53B+2.69%+13.78%-2.0%
Q3 FY20230.590.590.00%-3.28%1.48B1.48B+0.14%+12.27%-8.2%
Q2 FY20230.650.66+1.54%+4.76%1.50B1.53B+1.81%+11.38%-9.8%
Q1 FY20230.610.62+1.64%+3.33%1.39B1.46B+4.79%+8.83%-0.8%
Q4 FY20220.610.64+4.92%+25.49%1.33B1.35B+1.09%+1.40%+6.3%
Q3 FY20220.620.61-1.61%+12.96%1.33B1.32B-1.12%+0.67%-18.0%
Q2 FY20220.640.63-1.56%-1.56%1.40B1.37B-1.60%-0.15%-6.2%
Q1 FY20220.570.60+5.26%+11.11%1.31B1.34B+2.37%+10.24%-5.4%
Q4 FY20210.550.51-7.27%+2.00%1.35B1.33B-1.72%+11.58%-1.2%
Q3 FY20210.530.54+1.89%+5.88%1.33B1.31B-1.54%+14.84%+0.4%
Q2 FY20210.560.64+14.29%+88.24%1.38B1.38B0.00%+48.76%+0.4%
Q1 FY20210.470.54+14.89%+8.00%1.16B1.22B+4.45%+7.79%+6.2%
Q4 FY20200.530.50-5.66%+2.04%1.26B1.19B-5.36%+1.50%-1.9%
Q3 FY20200.440.51+15.91%+8.51%984.31M1.14B+15.91%+4.29%—
Q2 FY20200.150.34+126.67%-26.09%462.50M925.00M+100.00%-14.90%—
Q1 FY20200.440.50+13.64%+13.64%1.02B1.13B+11.11%+13.67%—
Q4 FY20190.500.49-2.00%+25.64%1.20B1.17B-2.00%+20.09%—
Q3 FY20190.410.47+14.63%+30.56%954.34M1.09B+14.63%+20.67%+1.7%
Q2 FY20190.440.46+4.55%+12.20%1.04B1.09B+4.55%+15.17%+9.9%
Q1 FY20190.410.44+7.32%+7.32%925.30M993.00M+7.32%+10.97%-1.8%
Q4 FY20180.390.390.00%+25.81%977.70M977.70M0.00%+10.04%-1.1%
Q3 FY20180.340.36+5.88%+28.57%856.23M906.60M+5.88%+10.36%-5.4%
Q2 FY20180.380.41+7.89%+28.13%874.65M943.70M+7.89%+12.11%-8.5%
Q1 FY20180.370.41+10.81%+32.26%814.12M894.80M+9.91%+1.28%-3.8%
Q4 FY20170.300.31+3.33%+24.00%860.14M888.50M+3.30%+15.74%+3.8%
Q3 FY20170.290.28-3.45%+21.74%841.06M821.50M-2.33%+11.10%-9.5%
Q2 FY20170.290.32+10.34%+28.00%685.91M841.80M+22.73%+10.87%+0.6%
Q1 FY20170.270.31+14.81%+29.17%770.71M883.50M+14.63%+26.70%+10.5%
Q4 FY20160.240.25+4.17%+19.05%736.99M767.70M+4.17%+14.39%-8.3%
Q3 FY20160.230.230.00%+27.78%739.40M739.40M0.00%+20.13%-17.1%
Q2 FY20160.230.25+8.70%+31.58%699.36M759.30M+8.57%+23.10%+5.6%
Q1 FY20160.220.24+9.09%+26.32%648.19M697.30M+7.58%+18.13%+0.1%
Q4 FY20150.210.210.00%+16.67%660.45M671.10M+1.61%+8.59%+8.3%
Q3 FY20150.160.18+12.50%+38.46%558.51M615.50M+10.20%+1.33%+2.8%
Q2 FY20150.180.19+5.56%+26.67%583.76M616.80M+5.66%+7.25%-1.3%
Q1 FY20150.170.19+11.76%+46.15%548.14M590.30M+7.69%+13.00%-2.5%
Q4 FY20140.160.18+12.50%+20.00%559.70M618.00M+10.42%+15.30%+6.2%
Q3 FY20140.120.13+8.33%+18.18%546.66M607.40M+11.11%+22.56%+11.0%
Q2 FY20140.130.15+15.38%+7.14%496.68M575.10M+15.79%+11.19%+10.0%
Q1 FY20140.110.13+18.18%+8.33%481.16M522.40M+8.57%+5.17%+0.3%
Q4 FY20130.140.15+7.14%0.00%477.74M536.00M+12.20%+5.00%+2.4%
Q3 FY20130.110.110.00%+10.00%481.02M495.60M+3.03%+10.65%-4.6%
Q2 FY20130.130.14+7.69%+27.27%479.36M517.20M+7.89%+7.30%+1.6%
Q1 FY20130.130.12-7.69%+33.33%524.29M496.70M-5.26%+8.17%-22.0%
Q4 FY20120.130.15+15.38%+50.00%431.09M510.50M+18.42%+18.67%-6.8%
Q3 FY20120.090.10+11.11%+66.67%432.46M447.90M+3.57%+8.53%+0.4%
Q2 FY20120.110.110.00%+37.50%467.82M482.00M+3.03%+11.78%+6.5%
Q1 FY20120.080.09+12.50%0.00%408.18M459.20M+12.50%+13.52%+11.6%
Q4 FY20110.100.100.00%+11.11%416.32M430.20M+3.33%+9.63%-11.3%
Q3 FY20110.070.06-14.29%-14.29%434.42M412.70M-5.00%+18.29%+6.2%
Q2 FY20110.080.080.00%0.00%431.20M431.20M0.00%+18.07%-5.6%
Q1 FY20110.070.09+28.57%+28.57%314.61M404.50M+28.57%+18.80%-1.2%
Q4 FY20100.090.090.00%+28.57%364.37M392.40M+7.69%+13.18%-0.9%
Q3 FY20100.070.070.00%+16.67%333.04M348.90M+4.76%+7.12%-0.6%
Q2 FY20100.070.08+14.29%+14.29%349.32M365.20M+4.55%+8.85%+7.1%
Q1 FY20100.070.070.00%+16.67%340.50M340.50M0.00%+8.61%-4.2%
Q4 FY20090.070.070.00%0.00%346.70M346.70M0.00%+11.95%+0.1%
Q3 FY20090.060.060.00%+20.00%307.61M325.70M+5.88%+7.28%+6.9%
Q2 FY20090.060.07+16.67%+16.67%318.73M335.50M+5.26%+2.41%-3.0%
Q1 FY20090.060.060.00%+20.00%296.08M313.50M+5.88%+5.63%+11.9%
Q4 FY20080.060.07+16.67%+40.00%294.22M309.70M+5.26%+5.70%+4.5%
Q3 FY20080.050.050.00%+25.00%303.60M303.60M0.00%+16.14%-7.9%
Q2 FY20080.050.06+20.00%+20.00%308.33M327.60M+6.25%+20.18%-2.7%
Q1 FY20080.040.05+13.87%0.00%254.40M296.80M+16.67%+12.38%+13.1%
Q4 FY20070.050.05+6.43%0.00%272.07M293.00M+7.69%+10.32%-3.5%
Q3 FY20070.040.04+7.93%0.00%239.62M261.40M+9.09%+5.66%-3.5%
Q2 FY20070.050.050.00%0.00%272.60M272.60M0.00%+1.98%-5.3%
Q1 FY20070.050.050.00%+25.00%264.10M264.10M0.00%+2.76%-6.0%
Q4 FY20060.050.05+3.67%+25.00%246.63M265.60M+7.69%+6.37%-4.4%
Q3 FY20060.040.04+0.81%0.00%247.40M247.40M0.00%+2.70%-3.9%
Q2 FY20060.050.05+7.99%+25.00%248.21M267.30M+7.69%+3.52%-3.7%
Q1 FY20060.040.04+2.99%0.00%236.95M257.00M+8.46%+3.17%+1.4%
Q4 FY20050.040.04+3.87%0.00%249.70M249.70M0.00%+5.31%+7.9%
Q3 FY20050.040.04+1.55%+33.33%220.83M240.90M+9.09%+7.16%-1.2%
Q2 FY20050.040.04+7.07%0.00%238.34M258.20M+8.33%+10.06%+8.1%
Q1 FY20050.040.04+6.38%+33.33%228.34M249.10M+9.09%+6.00%+0.5%
Q4 FY20040.040.04+2.20%0.00%215.55M237.10M+10.00%+5.80%-2.3%
Q3 FY20040.030.03-1.02%0.00%224.80M224.80M0.00%+9.07%+1.6%
Q2 FY20040.040.04+4.17%+33.33%213.27M234.60M+10.00%+7.71%+4.1%
Q1 FY20040.030.03-0.17%0.00%235.00M235.00M0.00%+10.59%+5.6%
Q4 FY20030.040.04+6.72%+33.33%203.73M224.10M+10.00%+10.34%-0.9%
Q3 FY20030.030.03-4.43%0.00%206.10M206.10M0.00%+24.31%-5.9%
Q2 FY20030.030.03-0.92%0.00%217.80M217.80M0.00%+26.04%-14.0%
Q1 FY20030.030.03+11.69%0.00%191.25M212.50M+11.11%+30.93%+6.9%
Q4 FY20020.030.03+5.45%+50.00%203.10M203.10M0.00%+27.02%+5.7%
Q3 FY20020.030.03+1.63%+50.00%165.80M165.80M0.00%+12.18%+6.3%
Q2 FY20020.030.03+2.56%+50.00%172.80M172.80M0.00%-10.19%+17.9%
Q1 FY20020.030.03+6.69%+50.00%144.27M162.30M+12.50%-15.42%-9.0%
Q4 FY20010.020.02+2.04%0.00%160.00M159.90M-0.06%-26.14%+10.0%
Q3 FY20010.020.02+3.20%0.00%148.00M147.80M-0.14%-20.45%-3.5%
Q2 FY20010.020.02+7.30%0.00%192.00M192.40M+0.21%-14.87%+3.7%
Q1 FY20010.020.02+7.30%—192.00M191.90M-0.05%—+12.5%
Q4 FY20000.020.02+10.07%-76.85%160.29M216.50M+35.07%-7.48%+7.1%
Q3 FY20000.020.020.00%—186.00M185.80M-0.11%—-3.3%
Q2 FY20000.04-0.44-1,206.10%—205.00M205.00M0.00%—-0.3%
Q2 FY20000.020.020.00%—205.00M226.00M+10.24%—-1.6%
Q4 FY1999—0.09———234.00M———

The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.

Beat record

On average, analysts' EPS estimate was 5.4% off the result, either way, and their revenue estimate 4.3%, over the last 12 quarters.

EPS beats
73 / 107
Revenue beats
73 / 107
Average EPS surprise, last 12
+4.4%
Since
August 2000

See also:Forecast,EPS,Income statement

Common questions about Edwards Lifesciences's earnings

Source: Financial Modeling Prep